Prof. Joseph Levine, M.D. is an associate professor in the Division of Psychiatry, Faculty of Health Sciences, Ben Gurion University in Israel. Prof. Levine is a certified psychiatrist with clinical experience in controlled trials of adult psychiatric disorders and has been awarded a NRSAD independent investigator grant for the study of Creatine Monohydrate in psychiatric disorders -- mainly Schizophrenia.
Yossi Levine
Prof. Joseph Levine is a Specialist in Psychiatry with more than 29 years of experience in Psychiatry. Prof. Levine is a former Director of the adult and forensic Psychiatric Wards and Outpatient Clinic in Israel. He is currently a Director of the Psychogeriatric division (Wards and Outpatient Clinic) at the Beersheva Mental Health Center, Isreal.
Prof. Levine has a Doctor of Medicine degree from the Sackler School of Medicine, University of Tel Aviv (Isreal, 1982), and his M.A. Sci. (cum laude) degree in Physiology and Pharmacology from the University of Tel Aviv (1985). He is also an Examiner for Specialization in Psychiatry on behalf of the Scientific Council of Israel.
He had received 3 years of training in psychotherapy and another 2 years of training in family therapy, from the Sackler School of Medicine, Tel Aviv University. He also has a diploma in Hypnosis form the Israeli Ministry of Health.
Between the years 1997 and 2000, Prof. Levine was undergoing 3 years of research in the bipolar unit and the Neurophysics Laboratory of the psychiatric department of the University of Pittsburgh, U.S.A.
Since 2002, Prof. Levine is an Associate Professor in the Psychiatric Division of the Faculty of Health Sciences at Ben Gurion University of the Negev.
Since 1987, Prof. Levine has published more than 150 scientific manuscripts and book chapters in the international scientific literature.
In collaboration with Prof. RH Belmaker, Prof. S Gershon, Prof. KN Chengappa, and Prof. JW Pettegrew, Prof. Levine has explored the efficacy of a variety of innovative therapeutic drug treatments in psychiatric disorders, including Anxiety Disorders, Depression, Eating Disorders, Bipolar illness and Schizophrenia. Such treatments included Myo-Inositol, Acetylcarnitine and Creatine, among others. In recent years, he is also exploring the role of Homocysteine as a risk factor in Schizophrenia (together with RH Belmaker), PTSD, and Eating Disorders.